CERo Therapeutics Holdings Financial Overview
CERo Therapeutics Holdings's market cap is currently $1.53M. The company's EPS TTM is $-38.986; its P/E ratio is ―; CERo Therapeutics Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.